ArticleAnnals of biomedical engineering2026
CRISPR Epigenome Editing of IL1R1 Expression of Neurons that Innervate the Temporomandibular Joint or Knee Causes Reduced Sensitization to Osteoarthritic Environment.
Article in Annals of biomedical engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
purposeOsteoarthritis (OA) pain can arise from inflammatory cytokines sensitizing neurons that innervate the temporomandibular joint (TMJ) and knee. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-based epigenome editing enables targeted repression of inflammatory receptors and offers a promising strategy to modify disease mechanisms. This study tested whether CRISPR epigenome editing of interleukin-1 receptor type 1 (IL1R1) in trigeminal ganglia (TG; TMJ-innervating) and dorsal root ganglia (DRG; knee-innervating) neurons could reduce OA-associated sensitization.
methodsOA cartilage was collected from knee replacement patients and compared with healthy cadaveric cartilage. Rat TG and DRG neurons were cultured with IL-1β on tissue culture plastic or cartilage explants, loaded with calcium dye, and subjected to thermal stimulation. Neurons were transduced with lentiviral CRISPR-dCas9-KRAB vectors targeting IL1R1 or with nontargeting controls, and heat-evoked calcium transients were measured.
resultsExposure to IL-1β and OA cartilage both increased the proportion of TG and DRG neurons exhibiting heat-induced calcium transients compared with controls. CRISPR epigenome editing of IL1R1 abolished sensitization in DRG neurons, restoring responses to healthy cartilage levels. In TG neurons, editing reduced maximum calcium responses to baseline but did not fully normalize the percentage of sensitized cells, suggesting additional OA factors contribute to TMJ pain.
conclusionCRISPR epigenome editing of IL1R1 in joint-innervating neurons reduces OA cartilage-induced sensitization. These results highlight differential mechanisms underlying OA cartilage driven DRG and TG neuron sensitization and establish epigenome editing as a potential therapeutic strategy to target OA-associated sensitization in the knee and TMJ.
Indexed as
Identifiers
41949727What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.